Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin J Boeree

Showing results (31-40 of 123) with videos related to

Pageof 13
Sort By:
American Journal of Respiratory and Critical Care Medicine|August 7, 2007
Impact of new American Thoracic Society diagnostic criteria on management of nontuberculous mycobacterial infectionJakko van Ingen, Martin J Boeree, Wiel C M de Lange, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|November 1, 2011
Are phylogenetic position, virulence, drug susceptibility and in vivo response to treatment in mycobacteria interrelated?Jakko van Ingen, Martin J Boeree, Dick van Soolingen, et al.
Diagnostic Microbiology and Infectious Disease|July 21, 2018
Mycobacterium avium complex bacteria remain viable in sputum during storage and refrigerationLian J Pennings, Sanne Zweijpfenning, Mike M Ruth, et al.
The European Respiratory Journal|December 10, 2015
Regimens for nontuberculous mycobacterial lung disease lack early bactericidal activityMichiel H C Slaats, Wouter Hoefsloot, Cecile Magis-Escurra, et al.
Tropical Medicine & International Health : TM & IH|April 23, 2010
Antituberculosis drug-induced hepatotoxicity is uncommon in Tanzanian hospitalized pulmonary TB patientsAlma Tostmann, Jossy van den Boogaard, Hadija Semvua, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 2008
Tuberculosis transmission by patients with smear-negative pulmonary tuberculosis in a large cohort in the NetherlandsAlma Tostmann, Sandra V Kik, Nico A Kalisvaart, et al.
Veterinary Microbiology|June 15, 2010
Disseminated Mycobacterium avium subsp. avium infection in a cat, the NetherlandsPiet Hein S de Groot, Jakko van Ingen, Rina de Zwaan, et al.
International Journal of Antimicrobial Agents|April 10, 2023
Model-based analysis of bactericidal activity and a new dosing strategy for optimised-dose rifampicinBudi O Susanto, Elin M Svensson, Lindsey Te Brake, et al.
Plos Computational Biology|April 13, 2023
High rifampicin peak plasma concentrations accelerate the slow phase of bacterial decline in tuberculosis patients: Evidence for heteroresistanceAntal Martinecz, Martin J Boeree, Andreas H Diacon, et al.
The European Respiratory Journal|April 20, 2019
Outcomes of hypertonic saline inhalation as a treatment modality in nontuberculous mycobacterial pulmonary diseaseAnne Huiberts, Sanne M H Zweijpfenning, Lian J Pennings, et al.
Pageof 13

Showing results (31-40 of 123) with videos related to

Sort By:
Pageof 13
American Journal of Respiratory and Critical Care Medicine|August 7, 2007
Impact of new American Thoracic Society diagnostic criteria on management of nontuberculous mycobacterial infectionJakko van Ingen, Martin J Boeree, Wiel C M de Lange, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|November 1, 2011
Are phylogenetic position, virulence, drug susceptibility and in vivo response to treatment in mycobacteria interrelated?Jakko van Ingen, Martin J Boeree, Dick van Soolingen, et al.
Diagnostic Microbiology and Infectious Disease|July 21, 2018
Mycobacterium avium complex bacteria remain viable in sputum during storage and refrigerationLian J Pennings, Sanne Zweijpfenning, Mike M Ruth, et al.
The European Respiratory Journal|December 10, 2015
Regimens for nontuberculous mycobacterial lung disease lack early bactericidal activityMichiel H C Slaats, Wouter Hoefsloot, Cecile Magis-Escurra, et al.
Tropical Medicine & International Health : TM & IH|April 23, 2010
Antituberculosis drug-induced hepatotoxicity is uncommon in Tanzanian hospitalized pulmonary TB patientsAlma Tostmann, Jossy van den Boogaard, Hadija Semvua, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 2008
Tuberculosis transmission by patients with smear-negative pulmonary tuberculosis in a large cohort in the NetherlandsAlma Tostmann, Sandra V Kik, Nico A Kalisvaart, et al.
Veterinary Microbiology|June 15, 2010
Disseminated Mycobacterium avium subsp. avium infection in a cat, the NetherlandsPiet Hein S de Groot, Jakko van Ingen, Rina de Zwaan, et al.
International Journal of Antimicrobial Agents|April 10, 2023
Model-based analysis of bactericidal activity and a new dosing strategy for optimised-dose rifampicinBudi O Susanto, Elin M Svensson, Lindsey Te Brake, et al.
Plos Computational Biology|April 13, 2023
High rifampicin peak plasma concentrations accelerate the slow phase of bacterial decline in tuberculosis patients: Evidence for heteroresistanceAntal Martinecz, Martin J Boeree, Andreas H Diacon, et al.
The European Respiratory Journal|April 20, 2019
Outcomes of hypertonic saline inhalation as a treatment modality in nontuberculous mycobacterial pulmonary diseaseAnne Huiberts, Sanne M H Zweijpfenning, Lian J Pennings, et al.
Pageof 13